These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 26812086

  • 1. Computationally Guided Identification of Novel Mycobacterium tuberculosis GlmU Inhibitory Leads, Their Optimization, and in Vitro Validation.
    Mehra R, Rani C, Mahajan P, Vishwakarma RA, Khan IA, Nargotra A.
    ACS Comb Sci; 2016 Feb 08; 18(2):100-16. PubMed ID: 26812086
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Identification and optimization of Escherichia coli GlmU inhibitors: an in silico approach with validation thereof.
    Mehra R, Sharma R, Khan IA, Nargotra A.
    Eur J Med Chem; 2015 Mar 06; 92():78-90. PubMed ID: 25544688
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Identification and characterization of novel small molecule inhibitors of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU).
    Sharma R, Rani C, Mehra R, Nargotra A, Chib R, Rajput VS, Kumar S, Singh S, Sharma PR, Khan IA.
    Appl Microbiol Biotechnol; 2016 Apr 06; 100(7):3071-85. PubMed ID: 26563552
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Kinetic properties of Mycobacterium tuberculosis bifunctional GlmU.
    Zhou Y, Xin Y, Sha S, Ma Y.
    Arch Microbiol; 2011 Oct 06; 193(10):751-7. PubMed ID: 21594607
    [Abstract] [Full Text] [Related]

  • 10. Substrate-bound crystal structures reveal features unique to Mycobacterium tuberculosis N-acetyl-glucosamine 1-phosphate uridyltransferase and a catalytic mechanism for acetyl transfer.
    Jagtap PK, Soni V, Vithani N, Jhingan GD, Bais VS, Nandicoori VK, Prakash B.
    J Biol Chem; 2012 Nov 16; 287(47):39524-37. PubMed ID: 22969087
    [Abstract] [Full Text] [Related]

  • 11. A web server for predicting inhibitors against bacterial target GlmU protein.
    Singla D, Anurag M, Dash D, Raghava GP.
    BMC Pharmacol; 2011 Jul 06; 11():5. PubMed ID: 21733180
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Escherichia coli N-Acetylglucosamine-1-Phosphate-Uridyltransferase/Glucosamine-1-Phosphate-Acetyltransferase (GlmU) Inhibitory Activity of Terreic Acid Isolated from Aspergillus terreus.
    Sharma R, Lambu MR, Jamwal U, Rani C, Chib R, Wazir P, Mukherjee D, Chaubey A, Khan IA.
    J Biomol Screen; 2016 Apr 06; 21(4):342-53. PubMed ID: 26762501
    [Abstract] [Full Text] [Related]

  • 18. An aminoquinazoline inhibitor of the essential bacterial cell wall synthetic enzyme GlmU has a unique non-protein-kinase-like binding mode.
    Larsen NA, Nash TJ, Morningstar M, Shapiro AB, Joubran C, Blackett CJ, Patten AD, Boriack-Sjodin PA, Doig P.
    Biochem J; 2012 Sep 15; 446(3):405-13. PubMed ID: 22721802
    [Abstract] [Full Text] [Related]

  • 19. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y, Zhou S, Deng Q, Li X, Meng J, Guan Y, Li C, Xiao C.
    Tuberculosis (Edinb); 2016 Mar 15; 97():38-46. PubMed ID: 26980494
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.